- Home
- BLMN vs OCUL Comparison
BLMN vs OCUL Comparison
Compare BLMN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- OCUL
- Stock Information
- Founded
- BLMN 1988
- OCUL 2006
- Country
- BLMN United States
- OCUL United States
- Employees
- BLMN N/A
- OCUL N/A
- Industry
- BLMN Restaurants
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- BLMN Consumer Discretionary
- OCUL Health Care
- Exchange
- BLMN Nasdaq
- OCUL Nasdaq
- Market Cap
- BLMN 1.4B
- OCUL 1.4B
- IPO Year
- BLMN 2012
- OCUL 2014
- Fundamental
- Price
- BLMN $11.95
- OCUL $8.50
- Analyst Decision
- BLMN Hold
- OCUL Strong Buy
- Analyst Count
- BLMN 11
- OCUL 8
- Target Price
- BLMN $18.00
- OCUL $16.50
- AVG Volume (30 Days)
- BLMN 1.9M
- OCUL 891.4K
- Earning Date
- BLMN 11-08-2024
- OCUL 11-14-2024
- Dividend Yield
- BLMN 8.03%
- OCUL N/A
- EPS Growth
- BLMN N/A
- OCUL N/A
- EPS
- BLMN N/A
- OCUL N/A
- Revenue
- BLMN $4,547,161,000.00
- OCUL $61,442,000.00
- Revenue This Year
- BLMN N/A
- OCUL $11.40
- Revenue Next Year
- BLMN N/A
- OCUL $13.58
- P/E Ratio
- BLMN N/A
- OCUL N/A
- Revenue Growth
- BLMN N/A
- OCUL 6.45
- 52 Week Low
- BLMN $11.80
- OCUL $3.76
- 52 Week High
- BLMN $30.13
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- BLMN 35.88
- OCUL 38.29
- Support Level
- BLMN $12.42
- OCUL $8.15
- Resistance Level
- BLMN $13.09
- OCUL $9.21
- Average True Range (ATR)
- BLMN 0.55
- OCUL 0.48
- MACD
- BLMN -0.01
- OCUL -0.07
- Stochastic Oscillator
- BLMN 5.80
- OCUL 16.99
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.